• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Coral
    |
    Weekly News Recap #Phispers
    Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly’s Foundayo in cross-trial comparison

    Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly’s Foundayo in cross-trial comparison

    In Phispers this week, Neurocrine Biosciences announced the acquisition of rare-disease drugmaker Soleno Therapeutics for US$ ...

    Impressions : 1505

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.